By Alex Anderssen in #MEAction.
Queen Mary University of London (QMUL) have issued a statement in response to Tuesday’s tribunal ruling that they must release anonymised PACE trial data to a patient who requested it under the Freedom of Information Act.
The data would allow the calculation of main outcome and recovery figures using analyses that were specified in PACE’s original protocol but abandoned during the trial. The protocol-specified results are expected to reduce estimates of recovery in PACE very considerably, in what is likely to be an embarrassing outcome for the authors and the journals who published their work.
QMUL said, “This has been a complex case and the Tribunal’s decision is lengthy. We are studying the decision carefully and considering our response, taking into account the interests of trial participants and the research community.”
Over forty scientists and clinicians from the ME/CFS research community signed an open letter to The Lancet in February asking for independent reanalysis of the PACE data, but QMUL’s statement makes no reference to it.
QMUL added that they had “shared data from the PACE trial with other researchers only when there is a confidentiality agreement in place and an agreed pre-specified statistical plan for data analysis.”
To read the rest of this story, click on the link below: